Dispensys AG has been acquired by Sulzer Mixpac AG
November 2010 — The owner of Dispensys AG has sold the company to Sulzer Mixpac AG. Financial details of this transaction have not been disclosed.
Dispensys develops and produces dispensers and cartridges for every 2-component application in the dental market such as for impression materials, temporary crown and bridge materials, cements, bleaching products and others. The owner of Dispensys wanted to focus on the development of new products.
Sulzer Mixpac is the world’s leading manufacturer and supplier of metering, mixing and dispensing systems and disposable mixers for reactive multicomponent materials.
Our role in the transaction
Oaklins' team in Switzerland acted as the exclusive financial advisor to the seller.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more